Azita Haddadi
Overview
Explore the profile of Azita Haddadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khajavinia A, Yarahmadi M, El-Aneed A, Haddadi A
J Pharm Biomed Anal
. 2022 Nov;
223:115114.
PMID: 36347105
Docetaxel is among the most effective chemotherapeutic agents used for the treatment of solid tumors, such as breast cancer. Targeting docetaxel to the tumor site would increase the safety and...
2.
Choudhary P, Khajavinia A, Mohammadi R, Ng S, Berube N, Yalamati D, et al.
Front Vet Sci
. 2022 Aug;
9:931232.
PMID: 35990278
An effective single-dose vaccine that protects the dam and her suckling offspring against infectious disease would be widely beneficial to livestock animals. We assessed whether a single-dose intramuscular (i.m.) porcine...
3.
Zandi M, Shokri S, Mahmoudvand S, Hosseinzadeh Adli A, Mohammadi R, Haddadi A
J Med Virol
. 2022 Jul;
94(11):5163-5173.
PMID: 35869415
Viruses as intracellular pathogens take over the host metabolism and reprogram to facilitate optimal virus production. DNA viruses can cause alterations in several metabolic pathways, including aerobic glycolysis also known...
4.
Wilson H, Haddadi A, Mutwiri G
Vaccines (Basel)
. 2021 Jul;
9(6).
PMID: 34207033
The ultimate goal for vaccination is the generation of a safe and effective immune response that protects against diseases [...].
5.
Khajavinia A, Haddadi A, El-Aneed A
Rapid Commun Mass Spectrom
. 2021 Apr;
35(13):e9107.
PMID: 33864637
Rationale: Compounds in the taxane drug family are among the most successful and effective chemotherapeutic agents used in the treatment of solid tumors, such as breast, ovarian, and prostate cancers....
6.
Haddadi A, Chaffey A, Ng S, Yalamati D, Wilson H
Vaccines (Basel)
. 2020 Oct;
8(4).
PMID: 33019524
The development of new, effective, and safe vaccines necessarily requires the identification of new adjuvant(s) to enhance the potency and longevity of antigen-specific immune responses. In the present study, we...
7.
Uludag H, Parent K, Montazeri Aliabadi H, Haddadi A
Front Bioeng Biotechnol
. 2020 Aug;
8:916.
PMID: 32850752
COVID-19 caused by the SARS-CoV-2 virus is a fast emerging disease with deadly consequences. The pulmonary system and lungs in particular are most prone to damage caused by the SARS-CoV-2...
8.
Rafiei P, Haddadi A
Mater Sci Eng C Mater Biol Appl
. 2019 Sep;
104:109950.
PMID: 31499976
Poly (lactide-co-glycolide) (PLGA) is a biocompatible, biodegradable, and non-toxic polymer used in a variety of biomedical and pharmaceutical applications. Polymeric nanoparticles prepared from PLGA have been extensively used as delivery...
9.
Jahan S, Sadat S, Yarahmadi M, Haddadi A
Mol Pharm
. 2018 Nov;
16(2):498-509.
PMID: 30477303
Targeted delivery of vaccine has the potential to localize the therapeutic agent to a target tissue with minimum side-effects. This article presents the development of a model targeted immunotherapeutic approach...
10.
Furber K, Van Agten M, Evans C, Haddadi A, Doucette J, Nazarali A
Degener Neurol Neuromuscul Dis
. 2018 Jul;
7:47-60.
PMID: 30050377
Multiple sclerosis (MS) is a progressive, neurodegenerative disease with unpredictable phases of relapse and remission. The cause of MS is unknown, but the pathology is characterized by infiltration of auto-reactive...